↓ Skip to main content

Cognitive remediation in the early course of schizophrenia: a critical review.

Overview of attention for article published in Current Pharmaceutical Design, January 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 X users

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
93 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cognitive remediation in the early course of schizophrenia: a critical review.
Published in
Current Pharmaceutical Design, January 2012
DOI 10.2174/138161212799316091
Pubmed ID
Authors

Stefano Barlati, Luca De Peri, Giacomo Deste, Paolo Fusar-Poli, Antonio Vita

Abstract

The aim of cognitive remediation is to target the cognitive impairments of patients with psychosis, including attentional deficits, memory problems, and limitations in planning and problem solving. It is hoped that by addressing these deficits, patients will be more able to take advantage of other interventions and will be more able to function in social and other domains. Many results in controlled trials of cognitive remediation in adult patients affected by schizophrenia have demonstrated its effectiveness on different cognitive domains and on patient's functioning. Some researchers speculate that deficits in cognition are more amenable to remediation during earlier phases of illness than when chronicity has developed. For these reasons cognitive rehabilitation should be a key component of early intervention programs, seeking to produce durable functional changes in the early course of schizophrenia. Although there is strong evidence that cognitive remediation is effective in adult schizophrenia, there is little evidence about its efficacy and long-term generalized effectiveness in the early course of the disease, and its possible application in the prodromal phase of the disease.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Iran, Islamic Republic of 1 1%
United States 1 1%
Portugal 1 1%
Denmark 1 1%
Unknown 89 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 17 18%
Researcher 13 14%
Student > Bachelor 13 14%
Other 8 9%
Student > Master 8 9%
Other 16 17%
Unknown 18 19%
Readers by discipline Count As %
Psychology 29 31%
Medicine and Dentistry 12 13%
Neuroscience 12 13%
Nursing and Health Professions 4 4%
Agricultural and Biological Sciences 4 4%
Other 7 8%
Unknown 25 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 January 2012.
All research outputs
#16,581,410
of 25,377,790 outputs
Outputs from Current Pharmaceutical Design
#2,416
of 3,701 outputs
Outputs of similar age
#167,682
of 250,127 outputs
Outputs of similar age from Current Pharmaceutical Design
#152
of 216 outputs
Altmetric has tracked 25,377,790 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,701 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 250,127 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 216 others from the same source and published within six weeks on either side of this one. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.